comparemela.com

Latest Breaking News On - Regeneron pharmaceuticals profile - Page 13 : comparemela.com

Bronte Capital Management Pty Ltd Purchases 3,126 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Bronte Capital Management Pty Ltd. raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 141,442 shares of the biopharmaceutical company’s stock after buying an additional 3,126 shares during the […]

Jackson Creek Investment Advisors LLC Sells 76 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Jackson Creek Investment Advisors LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 696 shares of the biopharmaceutical company’s stock after selling 76 shares during the quarter. Jackson Creek Investment […]

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Sold by Kendall Capital Management

Kendall Capital Management cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,772 shares of the biopharmaceutical company’s stock after selling 253 shares during the period. […]

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Bought by Choate Investment Advisors

Choate Investment Advisors increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 631 shares of the biopharmaceutical company’s stock after buying an additional 109 shares during the period. Choate Investment Advisors’ holdings in Regeneron […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.